Pathogenesis and therapy of amyotrophic lateral sclerosis /

Bibliographic Details
Corporate Author: Conference on Pathogenesis and Therapy of Amyotrophic Lateral Sclerosis
Other Authors: Serratrice, Georges, Munsat, Theodore L., 1930-
Format: Conference Proceeding Book
Language:English
Published: Philadelphia : Lippincott-Raven, [1995]
Series:Advances in neurology. v. 68.
Subjects:
Table of Contents:
  • Overview of the pathogenesis and therapy of amyotrophic lateral sclerosis
  • Excitotoxic mechanisms in the pathogenesis of amyotrophic lateral sclerosis
  • Excitotoxic mechanisms in the pathogenesis of amyotrophic lateral sclerosis : a discussion
  • The possible role of a secondary pathogenetic factor in amyotrophic lateral sclerosis
  • Copper/zinc superoxide dismutase mutations and free radical damage in amyotrophic lateral sclerosis
  • Autoimmunity as an etiological factor in sporadic amyotrophic lateral sclerosis
  • Amyotrophic lateral sclerosis : an autoimmune disease
  • Anti-calcium channel autoantibodies in amyotrophic lateral sclerosis : a review of the evidence
  • Animal models of amyotrophic lateral sclerosis
  • Animal models of amyotrophic lateral sclerosis : a discussion
  • Amyotrophic lateral sclerosis with paraproteins and autoantibodies
  • Amyotrophic lateral sclerosis with paraproteins and autoantibodies : a discussion
  • Chronic motor neuropathies
  • Amyotrophic lateral sclerosis : a multifactorial disease
  • The viral hypothesis
  • Neuropathology of the cortex in amyotrophic lateral sclerosis with dementia
  • The diagnosis of amyotrophic lateral sclerosis
  • Atypical amyotrophic lateral sclerosis
  • The diagnosis of amyotrophic lateral sclerosis : a discussion
  • Clues to the diagnosis of amyotrophic lateral sclerosis
  • Natural history of amyotrophic lateral sclerosis : quantification of symptoms, signs, strength and function
  • Natural history of amyotrophic lateral sclerosis : observations with the charing cross amyotrophic lateral sclerosis rating scales
  • Nautral history of amyotrophic lateral sclerosis : a discussion
  • Issues in amyotrophic lateral sclerosis clinical trial design
  • Megaslope, natural course and historical controls in amyotrophic lateral sclerosis trials
  • The design of clinical trials in amyotrophic lateral sclerosis
  • Use of growth factors in the treatment of motor neuron diseases
  • Neurotrophic factors as therapeutic agents in amyotrophic lateral sclerosis : potential and pitfalls
  • Neurotrophic factors and amyotrophic lateral sclerosis
  • Excitotoxic blocking strategies in amyotrophic lateral sclerosis
  • Excitotoxic blocking strategies in amyotrophic lateral sclerosis : a discussion
  • Should N-methyl-D-aspartate or non-N-methyl-D-aspartate glutamate receptor antagonists be used in amyotrophic lateral sclerosis
  • The biopharmaceutical industry and new drugs for amyotrophic lateral sclerosis
  • The biopharmaceutical industry and new drugs for amyotrophic lateral sclerosis : a discussion